Blue Trust Inc’s Sana Biotechnology SANA Stock Holding History

Blue Trust Inc’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3K	Hold	3,235	–	–	﹤0.01%	1839
2026 Q1	$9.32K	Sell	3,235 -1,481	-31%	-$5.83K	﹤0.01%	1859
2025 Q4	$19.2K	Sell	4,716 -1,790	-28%	-$8.02K	﹤0.01%	1694
2025 Q3	$23.1K	Sell	6,506 -13,014	-67%	-$47K	﹤0.01%	1623
2025 Q2	$53.3K	Sell	19,520 -6,397	-25%	-$13.2K	﹤0.01%	1441
2025 Q1	$43.5K	Sell	25,917 -13,910	-35%	-$38.9K	﹤0.01%	1433
2024 Q4	$64.9K	Buy	39,827 +26,698	+203%	+$79.6K	﹤0.01%	1126
2024 Q3	$71.7K	Buy	13,129 +12,154	+1,247%	+$63.9K	﹤0.01%	1402
2024 Q2	$9.75K	Buy	+975	New	+$7.77K	﹤0.01%	1934

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Blue Trust Inc's SANA Position: Q2 2026 in Review

Blue Trust Inc held its Sana Biotechnology (SANA) position steady in Q2 2026 at 3,235 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

Blue Trust Inc first reported a position in SANA in Q2 2024 and has held it in 9 quarters since. The position peaked at $71.7K in Q3 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Blue Trust Inc held 3,235 shares of Sana Biotechnology worth $11.3K as of Q2 2026.
Blue Trust Inc left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1839 holding.
Blue Trust Inc first reported a position in Sana Biotechnology in Q2 2024 and has held it in 9 quarters since.
Blue Trust Inc's Sana Biotechnology position peaked at $71.7K in Q3 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.